Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline

Journal of Urology

Volumn 188, Issue 6 SUPPL., 2012, Pages 2455-2463

  Gormley, E Ann ^a,b   Lightner, Deborah J ^a,b   Burgio, Kathryn L ^a,b   Chai, Toby C ^a,b   Clemens, J Quentin ^a,b   Culkin, Daniel J ^a,b   Das, Anurag Kumar ^a,b   Foster, Harris Emilio ^a,b   Scarpero, Harriette Miles ^a,b   Tessier, Christopher D ^a,b   Vasavada, Sandip Prasan ^a,b  

^a American Urological Association   (United States)

^b Society of Urodynamics   (United States)

Author keywords

guideline; nocturia; urinary bladder; urinary bladder, overactive; urinary incontinence

Indexed keywords

BOTULINUM TOXIN A; DARIFENACIN; FESOTERODINE; OXYBUTYNIN; SOLIFENACIN; TOLTERODINE; TROSPIUM CHLORIDE;

ALGORITHM; ARTICLE; BEHAVIOR THERAPY; BLADDER RECONSTRUCTION; BLURRED VISION; CINAHL; CLINICAL FEATURE; COGNITIVE DEFECT; CONCEPTUAL FRAMEWORK; CONSTIPATION; CONTROLLED DRUG RELEASE; CYSTALGIA; DRUG EFFICACY; DRY EYE; DYSPEPSIA; EMBASE; EVIDENCE BASED PRACTICE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GEL; HEMATURIA; HUMAN; INDWELLING CATHETER; LEG EDEMA; MEDLINE; NERVE STIMULATION; NOCTURIA; OVERACTIVE BLADDER; PATIENT EDUCATION; PATIENT MONITORING; PELVIC FLOOR MUSCLE TRAINING; PELVIS PAIN SYNDROME; PERCUTANEOUS TIBIAL NERVE STIMULATION; PHYSICAL EXAMINATION; POLYPHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; SACRAL NERVE STIMULATION; SYMPTOM; SYSTEMATIC REVIEW; TRANSDERMAL PATCH; TREATMENT PLANNING; URINALYSIS; URINARY DIVERSION; URINARY TRACT INFECTION; URINE CULTURE; URINE INCONTINENCE; XEROSTOMIA;

EID: 84868700750     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.09.079     Document Type: Article

References (40)

1. K.E. Hartmann, M.L. McPheeters, D.H. Biller Treatment of Overactive Bladder in Women Evidence Report/Technology Assessment Number 187 (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No. 290-2007-10065-I) 2009 Agency for Healthcare Research and Quality (AHRQ)
2. B.T. Haylen, D. de Ridder, R.M. Freeman An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction Neurourol Urodyn 29 2010 4
3. M.P. Fitzgerald, L. Brubaker Variability of 24-hour voiding diary variables among asymptomatic women J Urol 169 2003 207
4. P. Abrams, L. Cardozo, M. Fall The standardization of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society Neurourol Urodyn 21 2002 167
5. K.L. Burgio, B.T. Engel, J.L. Locher Normative patterns of diurnal urination across six age decades J Urol 145 1991 728
6. E. Van Haarst, E. Heldeweg, D. Newling The 24-h frequency-volume chart in adults reporting no voiding complaints: defining reference values and analysing variables Brit J Urol 93 2004 1257
7. K.T. McVary, C.G. Roehrborn, A.L. Avins American Urological Association Guideline: Management of Benign Prostatic Hyperplasia (BPH) Revised, 2010 2010 American Urological Association Education and Research, Inc
8. S.A. Shumaker, J.F. Wyman, J.S. Uebersax Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory Continence Program in Women (CPW) Research Group Qual Life Res 3 1994 291
9. K. Coyne, D. Revicki, T. Hunt Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q Qual Life Res 11 2002 563
10. K.S. Coyne, L.S. Matza, C. Thompson The responsiveness of the OAB-q among OAB patient subgroups Neurourol Urodynam 26 2007 196
11. G.J. Jarvis A controlled trial of bladder drill and drug therapy in the management of detrusor instability Brit J Urol 53 1981 565
12. K.L. Burgio, P.S. Goode, T.M. Johnson 2nd Behavioral versus drug treatment for overactive bladder in men: the male overactive bladder treatment in veterans (MOTIVE) trial J Am Geriatr Soc 59 2011 2209
13. J.A. Fantl, J.F. Wyman, D.K. McClish Efficacy of bladder training in older women with urinary incontinence JAMA 265 1991 609
14. H. Hashim, P. Abrams How should patients with an overactive bladder manipulate their fluid intake? Brit J Urol 102 2008 62
15. C.M. Bryant, C.J. Dowell, G. Fairbrother Caffeine reduction education to improve urinary symptoms Br J Nurs 11 2002 560
16. S. Kaya, T. Akbayrak, S. Beksac Comparison of different treatment protocols in the treatment of idiopathic detrusor overactivity: a randomized controlled trial Clin Rehabil 25 2011 327
17. R.M. Arruda, R.A. Castro, G.C. Sousa Prospective randomized comparison of oxybutynin, functional electrostimulation, and pelvic floor training for treatment of detrusor overactivity in women Int Urogynecol J Pelvic Floor Dysfunct 19 2008 1055
18. M. Colombo, G. Zanetta, S. Scalambrino Oxybutynin and bladder training in the management of female urge urinary incontinence: a randomized study Int Urogynecol J 6 1995 63
19. L.L. Subak, R. Wing, D.S. West Weight loss to treat urinary incontinence in overweight and obese women NEJM 360 2009 481
20. K.L. Burgio, J.L. Locher, P.S. Goode Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial JAMA 280 1998 1995
21. P.S. Goode, K.L. Burgio, J.L. Locher Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women J Am Geriatr Soc 50 2002 808
22. C. Song, J.T. Park, K.O. Heo Effects of bladder training and/or tolterodine in female patients with overactive bladder syndrome: a prospective, randomized study J Korean Med Sci 21 2006 1060
23. R. Kafri, R. Langer, Z. Dvir Rehabilitation vs drug therapy for urge urinary incontinence: short-term outcome Int Urogynecol J Pelvic Floor Dysfunct 18 2007 407
24. T.M. Johnson, K.L. Burgio, P.S. Goode Effects of behavioral and drug therapy on nocturia in older incontinent women J Am Geriatr Soc 53 2005 846
25. A. Mattiasson, J. Blaakaer, K. Hoye Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder Brit J Urol 91 2003 54
26. A. Mattiasson, A. Masala, R. Morton Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study Brit J Urol 2009 E-pub ahead of print
27. K.L. Burgio, S.R. Kraus, S. Menefee Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial Ann Intern Med 149 2008 161
28. C.J. Kelleher, L.D. Cardozo, V. Khullar A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance Br J Obstet Gynaecol 104 1997 988
29. J.S. Benner, M.B. Nichol, E.S. Rovner Patient-reported reasons for discontinuing overactive bladder medication Brit J Urol 105 2010 1276
30. A.O. D'Souza, M.J. Smith, L.A. Miller Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan J Manag Care Pharm 14 2008 291
31. R.B. Lipton, K. Kolodner, K. Wesnes Assessment of cognitive function of the elderly population: Effects of darifenacin J Urol 173 2005 493
32. G. Kay, T. Crook, L. Rekeda Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects European Urol 50 2006 317
33. V. Crentsil, M.O. Ricks, Q.L. Xue A pharmacoepidemiologic study of community-dwelling, disabled older women: Factors associated with medication use Amer J Geriatric Pharmacotherapy 8 2010 215
34. S.E. Sutherland, A. Lavers, A. Carlson Sacral nerve stimulation for voiding dysfunction: 0ne institution's 11-year experience Neurourol Urodyn 26 2007 19
35. K.M. Peters, S.A. MacDiarmid, L.S. Wooldridge Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: Results from the overactive bladder innovative therapy trial J. Urol 182 2009 1055
36. H.C. Klingler, A. Pycha, J. Schmidbauer Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study Urology 56 2000 766
37. S.A. MacDiarmid, K.M. Peters, S.A. Shobeiri Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder J Urol 183 2010 234
38. K.M. Peters, D.J. Carrico, R.A. Perez-Marrero Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial J Urol 183 2010 1438
39. S.M. Gilbert, T.W. Hensle Metabolic consequences and long-term complications of enterocystoplasty in children J Urol 173 2005 1080
40. P. Abrams, R. Freeman, C. Anderstrom Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder Brit J Urol 81 1998 801